IP Library Assignment 050004/0751
Patent Assignment
Reel/Frame 050004/0751

Security Interest

Recorded: 2019-08-08 Pages: 5
Assignor
NEUMEDICINES INC.
Executed: 2019-07-22
Assignee
NITTO AVECIA PHARMA SERVICES, INC.
10 VANDERBILT, IRVINE, CALIFORNIA, 92618
Covered Properties (12)
Uses of Il-12 in Hematopoiesis
Patent: 7,939,058 →
Application: 10/886,267 →
Publication: US 2005/0136034
A Method of Increasing Survival of a Human Subject Having Exposure to an Acute Exposure to Non-Therapeutic Whole Body Ionization by Administering a Therapeutically Effective Dose of Il-12
Patent: 8,921,315 →
Application: 12/430,016 →
Method for Treating Deficiency in Hematopoiesis
Patent: 9,023,337 →
Application: 12/756,988 →
Publication: US 2010/0278777
Method for Bone Marrow Preservation or Recovery
Patent: 9,402,882 →
Application: 12/756,995 →
Publication: US 2010/0278778
Uses of Il-12 in Hematopoiesis
Patent: 8,920,790 →
Application: 13/076,365 →
Publication: US 2011/0206635
Uses of Il-12 in Hematopoiesis
Patent: 9,173,922 →
Application: 13/356,515 →
Publication: US 2012/0190909
Il-12 Formulations for Enhancing Hematopoiesis
Patent: 9,878,012 →
Application: 13/697,940 →
Publication: US 2013/0129674
Methods for Radiation Protection by Administering Il-12
Patent: 9,636,381 →
Application: 13/745,698 →
Publication: US 2013/0243722
Uses of Il-12 and the Il-12 Receptor Positive Cell in Tissue Repair and Regeneration
Patent: 8,962,317 →
Application: 13/824,224 →
Publication: US 2013/0259828
Mitigation of Cutaneous Injury with Il-12
Patent: 9,925,246 →
Application: 14/125,887 →
Publication: US 2014/0205561
Il-12 for Radiation Protection and Radiation-Induced Toxicity Mitigation
Patent: 9,616,106 →
Application: 14/372,738 →
Publication: US 2014/0369958
Uses of Il-12 in Hematopoiesis
Application: 14/584,513 →
Publication: US 2015/0209409
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Jun 16, 2020
From: NEUMEDICINES INC.
To: FRIEDMAN, ELLIOT
Reel/Frame 052956/0270 →
Notice of Termination and Release of Patent Liens and Security Interests Jul 28, 2021
From: NEUMEDICINES INC.
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 057012/0881 →
Assignment of Assignor's Interest Dec 15, 2023
From: NEUMEDICINES INC.
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 065879/0436 →
Security Interest May 8, 2024
From: KARYOPHARM THERAPEUTICS INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 067345/0255 →
Second Lien Patent Security Agreement May 13, 2024
From: KARYOPHARM THERAPEUTICS INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 067396/0532 →
Patent Security Agreement Oct 10, 2025
From: KARYOPHARM THERAPEUTICS INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS AGENT
Reel/Frame 073058/0647 →
Patent Security Agreement Oct 10, 2025
From: KARYOPHARM THERAPEUTICS INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL TRUSTEE
Reel/Frame 073058/0504 →
Release of Security Interest in Patents at Reel/Frame No. 67396/0532 Oct 14, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS AGENT
To: KARYOPHARM THERAPEUTICS INC.
Reel/Frame 073111/0142 →